Live Breaking News & Updates on Meibomian gland disease

Stay informed with the latest breaking news from Meibomian gland disease on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Meibomian gland disease and stay connected to the pulse of your community

Tarsus To Participate In Fireside Chat At The 2024 Bank Of America Healthcare Conference

Tarsus To Participate In Fireside Chat At The 2024 Bank Of America Healthcare Conference
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Adrienne-kemp , David-nakasone , Bobak-azamian , Las-vegas , Nasdaq , Tarsus-pharmaceuticals-inc , Corporate-communications , Chief-executive-officer , America-healthcare-conference , Tarsus-pharmaceuticals

Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference

Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Las-vegas , David-nakasone , Adrienne-kemp , Bobak-azamian , Corporate-communications , Nasdaq , Tarsus-pharmaceuticals-inc , Chief-executive-officer , America-healthcare-conference , Tarsus-pharmaceuticals

Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

IRVINE, Calif., May 01, 2024 -- Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting...

United-states , Adrienne-kemp , David-nakasone , Corporate-communications , Nasdaq , Tarsus-pharmaceuticals-inc , Tarsus-pharmaceuticals , Meibomian-gland-disease , Markets ,

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon

IRVINE, Calif., April 23, 2024 -- Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,...

United-states , David-nakasone , Adrienne-kemp , Tarsus-pharmaceuticals-inc , Nasdaq , Corporate-communications , Exchange-commission , Pharmakon-advisors , Maturity-date , Biopharma-credit , Tarsus-pharmaceuticals , Meibomian-gland-disease

Tarsus Announces Pricing of $100.0 Million Public Offering

IRVINE, Calif., March 01, 2024 -- Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,...

United-states , North-carolina , New-york , Charlotte , David-nakasone , Adrienne-kemp , Goldman-sachs-co , Equity-syndicate-department , Corporate-communications , Syndicate-prospectus-department , Oppenheimer-co , Prospectus-department

Tarsus Announces Proposed $100.0 Million Public Offering

IRVINE, Calif., Feb. 29, 2024 -- Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,...

North-carolina , United-states , New-york , Charlotte , Adrienne-kemp , David-nakasone , Exchange-commission , Syndicate-prospectus-department , Prospectus-department , Oppenheimer-co , Nasdaq , Goldman-sachs-co

Tarsus Announces Proposed $100.0 Million Public Offering

Tarsus Announces Proposed $100.0 Million Public Offering
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Charlotte , North-carolina , United-states , New-york , Adrienne-kemp , David-nakasone , Company-or-tarsus , Equity-syndicate-department , Guggenheim-securities , Exchange-commission , Syndicate-prospectus-department , Oppenheimer-co

Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements

Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Adrienne-kemp , David-nakasone , Bobak-azamian , Corporate-communications , Exchange-commission , Tarsus-pharmaceuticals-inc , Nasdaq , Chief-executive-officer , Business-highlights , Care-providers , Meibomian-gland-disease

Tarsus Reports Strong Fourth Quarter And Full-Year 2023 Financial Results And Recent Business Achievements

Tarsus Reports Strong Fourth Quarter And Full-Year 2023 Financial Results And Recent Business Achievements
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Bobak-azamian , Tarsus-pharmaceuticals-inc , Nasdaq , Chief-executive-officer , Business-highlights , Corporate-update , Care-providers , Meibomian-gland-disease , Papulopustular-rosacea , Global-assessment ,

Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept "Tick-Kill" Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease -February 22, 2024 at 08:03 am EST

TP-05 demonstrated tolerability and statistically significant tick mortality, suggesting potential for on-demand Lyme disease prophylaxisIRVINE, Calif., Feb. 22, 2024 -- Tarsus Pharmaceuticals,...

United-states , Americans , Adrienne-kemp , David-nakasone , Centers-for-disease , Exchange-commission , Corporate-communications , Tarsus-pharmaceuticals-inc , Nasdaq , Disease-control , Tarsus-pharmaceuticals , Meibomian-gland-disease